The objective of the program is to acquire a specialized knowledge in corporate finance and early stage venture valuation for international capital increase in biotech-based companies in drug discovery processes. The main skills and topics are related with international entrepreneurship, Life Sciences sector in drug discovery, knowledge and technology transfer, intellectual property, early stage contracts and new drug candidates.
Pre-selection process: closed
Inscriptions Open: from October 2018 to January 2019
The students of our programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
Credits - 30 / European ECTS credits
Postgraduate Programs – 4th February 2019 to 30th May 2019.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English